Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Trends in Endocrinology   Volumes    Volume 1 
Abstract
Pregnancy-related pituitary disorders
Kursad Unluhizarci, Hulusi Atmaca, Fatih Tanriverdi, Fahrettin Kelestimur
Pages: 121 - 125
Number of pages: 5
Current Trends in Endocrinology
Volume 1 

Copyright © 2005 Research Trends. All rights reserved

ABSTRACT

During the pregnancy, the fetal-placental unit secretes proteins and steroid hormones into the mother’s bloodstream and this affects almost every endocrine gland in her body. It is well known that the pituitary gland is enlarged during pregnancy which is mainly due to diffuse and nodular hyperplasia of lactotrophs. Although pituitary adenomas, particularly prolactinomas, are no more numerous or larger in pregnant patients than in normal male and nonpregnant female subjects the hyperplasia of lactotrophs may have important clinical implications for the patient with a pre-existing prolactinoma. An increase in pituitary volume of more than two fold during pregnancy may make the pituitary gland more susceptible to ischemic necrosis after severe postpartum vaginal bleeding. Hyperplasia of the lactotroph cells stimulated by estrogens produced by the placenta and progesterone during pregnancy causes the pituitary to outgrow its blood supply, and may be a contributing factor in the development of postpartum pituitary necrosis (Sheehan’s syndrome). On the other hand, hypopituitarism developing during pregnancy may also be caused by lymphocytic hypophysitis and the differential diagnosis between these two disorders have paramount importance. The diagnosis of lymphocytic hypophysitis should be entertained in women with symptoms of hypopituitarism or mass lesions of the sella during pregnancy or postpartum period, especially in the absence of a history of obstetric hemorrhage. Pregnancy is associated with a lowering of the osmostat, the set point for plasma osmolality at which arginine vasopressin (AVP) is secreted, by 10 mOsm/kg. Thus pregnant women experience thirst and release AVP at lower levels of plasma osmolality than non-pregnant women. Borderline diabetes insipidus may manifest or the disease worsen during pregnancy because of increased vasopressin degradation caused by markedly increased levels of placental vasopressinase and pregnant women with diabetes insipidus should be treated appropriately. In conclusion, although the endocrine changes associated with pregnancy are adaptive, however, a woman may develop overt signs of a disease as a result of pregnancy.

Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms